Benchmark analyst Bill Sutherland reiterates Surgery Partners (NASDAQ:SGRY) with a Buy and maintains $47 price target.
Stevanato Group Appoints Ugo Gay As Chief Operations Officer
Strengthening corporate leadership aims to drive operational efficiencies and standardization of global processes.Stevanato Group S.p.A. (NYSE:STVN), a leading global provider of drug containment, drug delivery, and
